Search

everythinglearnresearchcommunity

for

Search:↓

Exposure to the hair loss drug finasteride during pregnancy can cause genital anomalies in male babies, but not in female babies. It's best to avoid this drug in women who could potentially become pregnant.

A genetic defect causes males in some Mediterranean populations to be born with ambiguous genitalia and develop male traits at puberty.

More research is needed to understand how testosterone is maintained in adult males.

Finasteride, when given in high oral doses to pregnant monkeys, caused genital abnormalities in male fetuses, but not in female fetuses or those exposed to intravenous finasteride.

Male hypogonadism affects skin and hair, causing thin skin, less hair, and skin reactions to treatment.

5AR inhibitors like finasteride and dutasteride improve hair growth and slow hair loss in male pattern baldness.

Laser hair removal before genital surgery can prevent complications and improve patient satisfaction.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

The creams are safe for pubic hair removal with minor, temporary skin irritation.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

Reduced Sonic hedgehog signaling leads to increased HPV replication and wart formation.

Stag parts were historically used in medicine for various health issues.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Finasteride use during early pregnancy may cause limb deformities in babies.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Testosterone therapy can improve skin and hair in men with low testosterone but may cause skin irritation with certain treatments.

Synthetic cannabinoid addiction can cause skin problems like acne and hair loss.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

A female dog with mixed male and female traits was treated successfully with surgery.

New genes and pathways are important for testosterone production and male sexual development.

Mutations in the androgen receptor gene cause androgen insensitivity, leading to female traits in genetically male individuals.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

Expanding premarital screening to include skin conditions, STDs, infertility, and male disorders can improve marriage stability.

Oral propranolol successfully treated a baby's skin growth and ulceration linked to PELVIS syndrome.

Finasteride can cause rare but serious skin rashes.